Alok Sonig - Dr Reddys President

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:4em;padding-top: 15px;;'>DR</div>
RDY -- USA Stock  

Upward Rally

  President
Mr. Alok Sonig serves as an Executive Vice President and Head North America Generics of the Dr. Reddy Laboratories Ltd. He joined us in June 2012 after 15 years with Bristol Myers Squibb, mostly based in Princeton. During his nearly 15 years at BristolMyers Squibb, Alok held several positions of increasing responsibilities in U.S. Pharmaceutical Group, Country assignments and Global Marketing. Alok served as the Managing Director of BMS India, based in Mumbai, from 20072010. He was Vice President and Head of Global Commercial Excellence, Strategy and Business Model Innovation during 20112012. During this assignment, he was instrumental in the development and deployment of Commercial Excellence capabilities worldwide. Prior to joining BMS, Alok was based in Washington D.C. and spent several years as a management consultant working in various industries on strategy and innovation assignments, including health care, technology and consumer marketing. He holds a Bachelors of Engineering from Punjab Engineering College in India and an M.B.A. from American University, Washington, D.C.
Age: 44  President Since 2015  MBA    
91 40 4900 2900  http://www.drreddys.com

Management Efficiency

The company has Return on Asset of 6.98 % which means that on every $100 spent on asset it made $6.98 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 18.75 % implying that it generated $18.75 on every 100 dollars invested.
The company has 811.73 M in debt with debt to equity (D/E) ratio of 20.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Dr Reddys Laboratories has Current Ratio of 1.92 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives

PRESIDENT Since

Joseph LaRosaRegeneron Pharmaceuticals
2019
Reshma KewalramaniVertex Pharmaceuticals Incorpor
2018
Charles MilsteinVertex Pharmaceuticals Incorpor
2017
John WesolowskiPerrigo Company Plc
2016
James MichaudPerrigo Company Plc
2016
Marion McCourtRegeneron Pharmaceuticals
2018
Jay MarkowitzRegeneron Pharmaceuticals
2017
Amit SachdevVertex Pharmaceuticals Incorpor
2017
Charles WagnerVertex Pharmaceuticals Incorpor
2019
John HendricksonPerrigo Company Plc
2016
Clinton LewisZoetis
2018
Scott JamisonPerrigo Company Plc
2011
Michael StewartPerrigo Company Plc
2004
Roxanne LaganoZoetis
2015
Ian SmithVertex Pharmaceuticals Incorpor
2017
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
2014
Michael PariniVertex Pharmaceuticals Incorpor
2017
Ronald JanishPerrigo Company Plc
2015
George YancopoulosRegeneron Pharmaceuticals
2016
Douglas McCorkleRegeneron Pharmaceuticals
2007
Jeffrey NeedhamPerrigo Company Plc
2009

Entity Summary

Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 21966 people.Dr Reddys Laboratories Ltd (RDY) is traded on BATS Exchange in USA and employs 21,966 people.

Dr Reddys Laboratories Leadership Team

G Prasad, Co-Chairman of the Board, Chief Executive Officer, Managing Director
MARC KIKUCHI, Chief Executive Officer, North America Generics
Hans Hasler, Additional Independent Director
Leo Puri, Non-Executive Independent Director
Sandeep Poddar, Compliance Officer, Company Secretary
Satish Reddy, Co-Chairman of the Board
Kedar Upadhye, IR Contact Officer
Samiran Das, Executive Vice President Head - FTO and GGPM
Sauri Gudlavalleti, Global Head of Integrated Product Development Organization
YUGANDHAR PUVVALA, Global Head of Supply Chain
Amit Biswas, Executive Vice President - Integrated Product Development
Ravi Bhoothalingam, Non-Executive Independent Director
Alok Sonig, Senior Vice President & India Business Head (Generics)
Allan Oberman, Non-Executive Independent Director
J Ramachandran, Executive Vice President-Management Systems and Corporate Initiatives
Prasad Menon, Lead Non-Executive Independent Director
K Rao, Sr. Vice President & Head ? Chemical Technical Operations (CTO)
Abhijit Mukherjee, COO
Anil Namboodiripad, Global Head of Proprietary Products
Saumen Chakraborty, President, Chief Financial Officer and Global Head of ITBPE, Legal & Compliance and FMCRE
SANJAY SHARMA, Global Head of Manufacturing
Shikha Sharma, Non-Executive Independent Director
Sridar Iyengar, Non-Executive Independent Director
Ganadhish Kamat, Executive Vice President and Global Head-Quality
Sripada Chandrasekhar, President, Global Head of HR and Member of Management Council
Omkar Goswami, Non-Executive Independent Director
Erez Israeli, Chief Operating Officer and Global Head of Generics & PSAI
Kalpana Morparia, Non-Executive Independent Director
Bharat Doshi, Non-Executive Independent Director
J Moreau, Non-Executive Independent Director
Raymond Vre, Global Head of Biologics
Raghav Chari, Senior Vice President - Proprietary Products
Bruce Carter, Non-Executive Independent Director
Saunak Savla, IR Contact Officer
Ashok Ganguly, Non-Executive Independent Director
Umang Vohra, Executive Vice President Head - North America Generics
M Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets)
Cartikeya Reddy, Senior Vice President Head - Biologics
Anupam Puri, Non-Executive Independent Director
Archana Bhaskar, Chief Human Resource Officer
Deepak Sapra, Global Head of PSAI